Developer docs
API playgroundTry for free, no card

Search company profiles

Adhera Therapeutics

Full company profile

uuid00043n9

Namestring
Adhera Therapeutics
Legal namestring
Adhera Therapeutics
Websiteurl
adherathera.com
Company typeenum
Private
Founded yearint
1983
Descriptiontext

Adhera Therapeutics, despite its name and firmographic metadata describing it as a specialty pharmaceutical company founded in 1983, operates in practice as an Australian-facing online casino affiliate marketing website at adherathera.com. The site publishes comparative reviews, RTP analyses, bonus term breakdowns, and payment method guides for offshore online casino operators including Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, Wild Fortune, Dragon Slots, AzurSlot, and Dolly Casino. Its content targets Australian adult players seeking access to offshore gambling platforms in the regulatory gap created by the Interactive Gambling Act 2001.

The platform is a standard content publishing site without proprietary technology, algorithms, or distinctive technical infrastructure. It aggregates publicly available data on game libraries (3,000 to 11,000+ titles per operator), third-party safety scores (e.g., Casino Guru, AskGamblers), and benchmarked withdrawal speeds across PayID, crypto, e-wallet, and card payment rails. The underlying technology stack is not disclosed.

The business model is affiliate/referral commission: the site embeds tracked links (with parameters such as btag, stag, subid) that attribute player sign-ups and deposits to promoted casino operators, generating CPA or revenue-share commissions. There is no product pricing or subscription model; revenue is entirely performance-based against a small set of B2B affiliate partners. The stated 1–10 employee headcount is consistent with a small-scale affiliate operation rather than a pharmaceutical enterprise, and the historical financial figures attached to this name (revenue in hundreds of billions, large negative EBITDA) appear inconsistent with the current website footprint and should be treated as suspect or misattributed.

Short descriptiontext

Adhera Therapeutics operates adherathera.com, an Australian-focused online casino affiliate marketing site that publishes comparative reviews and referral links for offshore gambling operators targeting players in the Interactive Gambling Act 2001 grey area.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDurham, United States
HQ citystring
Durham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
online casino reviews, affiliate marketing, casino comparison, gambling affiliate, pokies reviews
Industry2 codes
1Casino/iCasino Affiliate & Review Sites
CodeMPAEAMABPrimaryYes
2Player Acquisition & Affiliate Networks for iCasino
CodeMPAEABALPrimaryNo
NAICS code2 codes
  • Advertising Agencies54181
  • Media Buying Agencies541830
SIC code2 codes
  • Services-Advertising Agencies7311
  • Services-Advertising7310
Product category
iGaming Affiliate Marketing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Affiliate / Referral Commissions
TypeAffiliate Referral
Description

The company monetizes through affiliate marketing arrangements with online casinos. The site promotes multiple casino operators (Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, Wild Fortune) using tracked affiliate links. Revenue is generated when referred users sign up, deposit, or engage with promoted casinos. The site earns commission based on player activity, deposit volumes, or CPA (cost-per-acquisition) arrangements typical in the iGaming affiliate space.

adherathera.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Marketing or Sales, Technology or R&D, Operations
GTM typeB2C
B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

Adhera Therapeutics operates an online affiliate marketing platform (adherathera.com) that publishes detailed reviews, RTP comparisons, bonus analyses, and payment method guides for offshore online casinos targeting Australian players. The website monetizes through affiliate commissions earned when referred users sign up and deposit at promoted casino brands including Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, and Wild Fortune.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Casino Guru safety ratings above 8.0 used as baseline for recommended casinos
+4 more records
Product and service1 record
1Online Casino Review and Comparison Platform (adherathera.com)
CategoryAffiliate Marketing Content Platform
Description

A content website providing detailed reviews, RTP comparisons, bonus term analyses, withdrawal speed benchmarks, and payment method guides for offshore online casinos targeting Australian adult players.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Australian-focused online pokies and casino review and affiliate site covering offshore operators, bonuses, and payment methods. Direct peer given identical Australian audience focus and casino affiliate GTM motion.

2ThePOGG
TypeDirect peer
Description

Independent casino review and complaint-resolution site with structured data on RTP, payouts, and bonus fairness. Comparable as a content-led casino affiliate in the same vertical.

TypeDirect peer
Description

Large casino review and complaint-resolution platform covering bonuses, game libraries, and player ratings. Directly comparable as a casino affiliate/content site whose player ratings the subject company cites as third-party validation.

TypeEmerging player
Description

Bonus-comparison and casino-affiliate site operating across multiple regulated and grey markets. Comparable affiliate GTM motion focused on bonus-driven acquisition and SEO content.

TypeEmerging player
Description

Online slots and casino review affiliate site publishing game and casino content for SEO-driven acquisition. Comparable niche casino-affiliate content platform with similar SEO-led GTM.

TypeDirect peer
Description

Online casino review and affiliate publisher producing structured casino, game, and bonus content. Directly comparable as a casino-affiliate content platform.

TypeDirect peer
Description

Casino bonus-tracking and review community that aggregates offers, wagering terms, and player feedback. Directly comparable affiliate and content platform monetizing casino referrals.

TypeDirect peer
Description

Long-running independent online casino review and player-protection platform. Comparable as a casino affiliate publisher emphasizing licensing, safety ratings, and bonus-term transparency.

TypeDirect peer
Description

Global casino review and rating platform that publishes detailed casino reviews, RTP data, bonus analysis, and independent safety ratings. Directly comparable as a casino affiliate and review site that the subject company itself references for safety scoring.

TypeDirect peer
Description

Large global casino review and affiliate site covering online casinos, bonuses, and game guides. Comparable casino-affiliate business model targeting similar player-intent search traffic.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Adhera Therapeutics

iGaming Affiliate Marketingadherathera.com

Adhera Therapeutics operates adherathera.com, an Australian-focused online casino affiliate marketing site that publishes comparative reviews and referral links for offshore gambling operators targeting players in the Interactive Gambling Act 2001 grey area.

What Adhera Therapeutics does

Adhera Therapeutics, despite its name and firmographic metadata describing it as a specialty pharmaceutical company founded in 1983, operates in practice as an Australian-facing online casino affiliate marketing website at adherathera.com. The site publishes comparative reviews, RTP analyses, bonus term breakdowns, and payment method guides for offshore online casino operators including Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, Wild Fortune, Dragon Slots, AzurSlot, and Dolly Casino. Its content targets Australian adult players seeking access to offshore gambling platforms in the regulatory gap created by the Interactive Gambling Act 2001.

The platform is a standard content publishing site without proprietary technology, algorithms, or distinctive technical infrastructure. It aggregates publicly available data on game libraries (3,000 to 11,000+ titles per operator), third-party safety scores (e.g., Casino Guru, AskGamblers), and benchmarked withdrawal speeds across PayID, crypto, e-wallet, and card payment rails. The underlying technology stack is not disclosed.

The business model is affiliate/referral commission: the site embeds tracked links (with parameters such as btag, stag, subid) that attribute player sign-ups and deposits to promoted casino operators, generating CPA or revenue-share commissions. There is no product pricing or subscription model; revenue is entirely performance-based against a small set of B2B affiliate partners. The stated 1–10 employee headcount is consistent with a small-scale affiliate operation rather than a pharmaceutical enterprise, and the historical financial figures attached to this name (revenue in hundreds of billions, large negative EBITDA) appear inconsistent with the current website footprint and should be treated as suspect or misattributed.

Adhera Therapeutics firmographics

Firmographics
Name
Adhera Therapeutics
Legal name
Adhera Therapeutics
Website
https://adherathera.com
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
1–10 employees
Short description
Adhera Therapeutics operates adherathera.com, an Australian-focused online casino affiliate marketing site that publishes comparative reviews and referral links for offshore gambling operators targeting players in the Interactive Gambling Act 2001 grey area.
Ownership category
akta.pro rank

Adhera Therapeutics industry classification

Industry
Product category
iGaming Affiliate Marketing
NAICS
Advertising Agencies (54181), Media Buying Agencies (541830)
SIC
Services-Advertising Agencies (7311), Services-Advertising (7310)
akta.pro primary industry
Casino/iCasino Affiliate & Review Sites (MPAEAMAB)
akta.pro secondary industry
Player Acquisition & Affiliate Networks for iCasino (MPAEABAL)

Keywords

  • Online casino reviews
  • Affiliate marketing
  • Casino comparison
  • Gambling affiliate
  • Pokies reviews

Where Adhera Therapeutics is headquartered

Location

Headquarters

HQ city
Durham
HQ country
United States
HQ region
North America

Markets served

Adhera Therapeutics business model

Business model
GTM type
B2C
Offering type
Digital Commerce or Content
Cost components
Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Affiliate / Referral Commissions: The company monetizes through affiliate marketing arrangements with online casinos. The site promotes multiple casino operators (Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, Wild Fortune) using tracked affiliate links. Revenue is generated when referred users sign up, deposit, or engage with promoted casinos. The site earns commission based on player activity, deposit volumes, or CPA (cost-per-acquisition) arrangements typical in the iGaming affiliate space.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Adhera Therapeutics product offering

Product offering

Core offering

Adhera Therapeutics operates an online affiliate marketing platform (adherathera.com) that publishes detailed reviews, RTP comparisons, bonus analyses, and payment method guides for offshore online casinos targeting Australian players. The website monetizes through affiliate commissions earned when referred users sign up and deposit at promoted casino brands including Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, and Wild Fortune.

Differentiator

Problem solved

Functional benefit

Products and services

  • Online Casino Review and Comparison Platform (adherathera.com) A content website providing detailed reviews, RTP comparisons, bonus term analyses, withdrawal speed benchmarks, and payment method guides for offshore online casinos targeting Australian adult players.

Quantifiable outcome

  • Casino Guru safety ratings above 8.0 used as baseline for recommended casinos
  • +4 more outcomes

Companies that use Adhera Therapeutics

Customer profile

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Adhera Therapeutics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Adhera Therapeutics partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Adhera Therapeutics competitors and assessment

Company assessment

Direct peers

  • Pokies.com: Australian-focused online pokies and casino review and affiliate site covering offshore operators, bonuses, and payment methods. Direct peer given identical Australian audience focus and casino affiliate GTM motion.
  • ThePOGG: Independent casino review and complaint-resolution site with structured data on RTP, payouts, and bonus fairness. Comparable as a content-led casino affiliate in the same vertical.
  • AskGamblers: Large casino review and complaint-resolution platform covering bonuses, game libraries, and player ratings. Directly comparable as a casino affiliate/content site whose player ratings the subject company cites as third-party validation.
  • OnlineCasinoReports: Online casino review and affiliate publisher producing structured casino, game, and bonus content. Directly comparable as a casino-affiliate content platform.
  • Latest Casino Bonuses (LCB): Casino bonus-tracking and review community that aggregates offers, wagering terms, and player feedback. Directly comparable affiliate and content platform monetizing casino referrals.
  • Casinomeister: Long-running independent online casino review and player-protection platform. Comparable as a casino affiliate publisher emphasizing licensing, safety ratings, and bonus-term transparency.
  • Casino Guru: Global casino review and rating platform that publishes detailed casino reviews, RTP data, bonus analysis, and independent safety ratings. Directly comparable as a casino affiliate and review site that the subject company itself references for safety scoring.
  • Casino.org: Large global casino review and affiliate site covering online casinos, bonuses, and game guides. Comparable casino-affiliate business model targeting similar player-intent search traffic.

Emerging players

  • BonusFinder: Bonus-comparison and casino-affiliate site operating across multiple regulated and grey markets. Comparable affiliate GTM motion focused on bonus-driven acquisition and SEO content.
  • SlotsUp: Online slots and casino review affiliate site publishing game and casino content for SEO-driven acquisition. Comparable niche casino-affiliate content platform with similar SEO-led GTM.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Adhera Therapeutics social profiles

Digital presence

Adhera Therapeutics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Adhera Therapeutics leadership team

Management profile

Number of profiles

Adhera Therapeutics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Adhera Therapeutics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adhera Therapeutics

What does Adhera Therapeutics do?

Adhera Therapeutics operates an online affiliate marketing platform (adherathera.com) that publishes detailed reviews, RTP comparisons, bonus analyses, and payment method guides for offshore online casinos targeting Australian players. The website monetizes through affiliate commissions earned when referred users sign up and deposit at promoted casino brands including Wonaco, Rocket Casino, Richard Casino, Bizzo Casino, and Wild Fortune.

Is Adhera Therapeutics a public or private company?

Adhera Therapeutics is a private company. It is classified as unknown and is currently operating.

When was Adhera Therapeutics founded?

Adhera Therapeutics was founded in 1983. It employs 1 to 10 people.

Where is Adhera Therapeutics based?

Adhera Therapeutics is headquartered in Durham, United States, in the North America region.

How does Adhera Therapeutics make money?

One revenue line is on record: affiliate / Referral Commissions.

Who are Adhera Therapeutics's main competitors?

Direct peers on record are Pokies.com, ThePOGG, AskGamblers, OnlineCasinoReports, Latest Casino Bonuses (LCB), Casinomeister, Casino Guru and Casino.org. Emerging players are BonusFinder and SlotsUp.

Does Adhera Therapeutics have an API?

No public API is recorded for Adhera Therapeutics.

What industry is Adhera Therapeutics in?

Adhera Therapeutics's product category is iGaming Affiliate Marketing. Its primary akta.pro industry code is MPAEAMAB, Casino/iCasino Affiliate & Review Sites, with a secondary code of MPAEABAL, Player Acquisition & Affiliate Networks for iCasino. Its NAICS code is 54181 and its SIC code is 7311.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American Banking and Market NewsBiohaven (NYSE:BHVN) & Adhera Therapeutics (OTCMKTS:ATRX) Head-To-Head SurveyBiohaven and Adhera Therapeutics are compared on risk, profitability, valuation, and analyst ratings. Biohaven has a lower beta, higher institutional ownership, and a stronger consensus rating with a $18.94 price target, implying 20% upside. Adhera's data is largely missing, making Biohaven the more favorable choice.GlobeNewswireBiodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment OptionBiodexa Pharmaceuticals PLC closed a $6.0 million underwritten public offering, including the full exercise of its overallotment option, to fund its clinical-stage drug pipeline. Simultaneously, the company finalized an agreement with Adhera Therapeutics to acquire exclusive worldwide rights to Tolimidone for a Type I Diabetes clinical program. The transaction also involved payments and equity issuances to Melior Pharmaceuticals and secured noteholders as part of the license acquisition.PR NewswireThinking about buying stock in Vistagen Therapeutics, Origin Materials, MedAvail Holdings, United States Lime & Minerals, or Adhera Therapeutics?InvestorsObserver issued PriceWatch Alerts for five specific stocks: Vistagen Therapeutics, Origin Materials, MedAvail Holdings, United States Lime & Minerals, and Adhera Therapeutics. The alerts are generated using the firm's proprietary scoring methodology which evaluates short-term technical, long-term technical, and fundamental factors to determine investment suitability.GlobeNewswireAdhera Therapeutics Provides Insight on Corporate Strategy, Development of Parkinson’s Disease and Type 1 Diabetes DrugsAdhera Therapeutics announced its strategy for MLR-1019 (armesocarb) for Parkinson's disease and MLR-1023 (tolimidone) for Type 1 diabetes, including Phase 2a trial plans. The company plans to initiate MLR-1019 trials in Eastern Europe and pivot MLR-1023 to Type 1 diabetes, citing market exclusivity and cost advantages. It also appointed Andrew G. Reaume to the board and is moving to OTCQB.ParkinsonsnewstodayMLR-1019 for Easing Parkinson’s Symptoms to Be Developed by AdheraAdhera Therapeutics has entered a licensing agreement with Melior Pharmaceuticals II to develop MLR-1019, a treatment candidate for Parkinson's disease that targets both motor and non-motor symptoms. Adhera acquired exclusive global rights to the intellectual property in exchange for milestone payments and royalties to Melior. The companies plan to move directly into Phase 2a clinical trials leveraging the proven safety profile of its precursor molecule, mesocarb.StocksToTradeATRX Stock Soars 360%: Why This Penny Stock Is RallyingAdhera Therapeutics Inc. executed a definitive license agreement with Melior Pharmaceuticals II, LLC for the development of MLR-1019, a Parkinson’s disease drug candidate. The deal grants Adhera exclusive worldwide rights to advance the compound into Phase 2a clinical trials using existing safety data, with payments triggered by clinical and FDA approval milestones. Following the announcement, Adhera's stock surged over 360% in early trading.